Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $620.8950 (-3%) ($617.8000 - $639.9900) on Fri. Jul. 10, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.71% (three month average) | RSI | 42 | Latest Price | $620.8950(-3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.1% a day on average for past five trading days. | Weekly Trend | REGN advances 0.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) XLV(45%) SPLV(39%) IVW(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -1.355% in a week (0% probabilities). VIXM(-21%) VXX(-7%) UUP(-6%) TBT(-6%) IYT(-4%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.355% (StdDev 2.71%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $633.45(-1.98%) | 10 Day Moving Average | $624.89(-0.64%) | 20 Day Moving Average | $617.84(0.49%) | To recent high | -3.4% | To recent low | 21.2% | Market Cap | $65.833b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |